KRAS and cancer: Murine pancreatic cancer cells saw the functional modification of exosomes that carry a specific siRNA for targeting oncogenic KRAS, explaining the potential of these exosomes for treating the malignant tumors with identified molecular targets (Xie et al., 2020).